{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:49:22Z","timestamp":1795034962628,"version":"4.10.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.pathol.2025.02.008","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T02:36:07Z","timestamp":1744943767000},"page":"730-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dual-reporting aldosterone by mass spectrometry and immunoassay in the seated saline suppression test may enhance subtype classification of patients with primary aldosteronism"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2645-9588","authenticated-orcid":false,"given":"Nicola","family":"Sawyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glendenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-0195","authenticated-orcid":false,"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-1288","authenticated-orcid":false,"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-6184","authenticated-orcid":false,"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2025.02.008_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2025.02.008_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2025.02.008_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2025.02.008_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pathol.2025.02.008_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2025.02.008_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5694\/mja17.00783","article-title":"Is it time to screen all patients with hypertension for primary aldosteronism?","volume":"209","author":"Yang","year":"2018","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2025.02.008_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41371-020-0336-2","article-title":"Primary aldosteronism is a public health issue: challenges and opportunities","volume":"34","author":"Libianto","year":"2020","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/a-2048-6213","article-title":"Improving detection rates for primary aldosteronism","volume":"131","author":"Libianto","year":"2023","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pathol.2025.02.008_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/HJH.0000000000001718","article-title":"Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions","volume":"36","author":"Vorselaars","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib11","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2025.02.008_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pathol.2023.02.002","article-title":"The adrenal vein sampling outcomes study (AVOS): success rates following adrenalectomy for unilateral primary aldosteronism","volume":"55","author":"Sawyer","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2025.02.008_bib14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib15","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib16","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib17","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chroma.2016.07.087","article-title":"Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair","volume":"1464","author":"Gaudl","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.pathol.2025.02.008_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jclinpath-2011-200564","article-title":"Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system","volume":"65","author":"Van Der Gugten","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pathol.2025.02.008_bib20","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib21","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib22","series-title":"Harmonisation of endocrine dynamic testing - adult","author":"Chiang","year":"2021"},{"key":"10.1016\/j.pathol.2025.02.008_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0004563218760352","article-title":"Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement","volume":"55","author":"Page","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2025.02.008_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib26","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","article-title":"Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays","volume":"33","author":"Manolopoulou","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib27","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","article-title":"Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis","volume":"108","author":"Sconfienza","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2025.02.008_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/jch.13291","article-title":"Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?","volume":"20","author":"Stavropoulos","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.pathol.2025.02.008_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2025.02.008_bib30","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2025.02.008_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pathol.2025.02.008_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2025.02.008_bib33","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2025.02.008_bib34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1210\/js.2018-00055","article-title":"Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism","volume":"2","author":"Umakoshi","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.pathol.2025.02.008_bib35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jfma.2020.04.016","article-title":"Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.pathol.2025.02.008_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cen.14610","article-title":"Indices of ACTH-stimulated adrenal venous sampling as predictors of postsurgical outcomes in primary aldosteronism","volume":"96","author":"Lee","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pathol.2025.02.008_bib37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/HYPERTENSIONAHA.123.22281","article-title":"Unilateral primary aldosteronism: long-term disease recurrence after adrenalectomy","volume":"81","author":"Tetti","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2025.02.008_bib38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism","volume":"78","author":"Meyer","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2025.02.008_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pathol.2025.02.008_bib40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2025.02.008_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:14:56Z","timestamp":1757070896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0031302525001576"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.02.008","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-reporting aldosterone by mass spectrometry and immunoassay in the seated saline suppression test may enhance subtype classification of patients with primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}